Analysis Article • Jul 14
Have your own idea? Try our Stock Screener
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedJul 17, 2026
DataAggregated Company Financials
Companies7
- 7D-2.9%
- 3M-10.5%
- 1Y-21.0%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 1.4%, driven by a pullback from Oxford Nanopore Technologies of 2.5%. On the other hand Proteome Sciences is actually up 15%. The industry has fallen 23% in the last year. Looking forward, earnings are forecast to grow by 52% annually.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 17 Jul 2026 | UK£1.3b | UK£323.1m | -UK£164,731,254.00 | 1174x | -8.1x | 4.1x |
| Sun, 14 Jun 2026 | UK£1.3b | UK£323.0m | -UK£166,018,254.00 | 1243.9x | -8.1x | 4.1x |
| Tue, 12 May 2026 | UK£1.4b | UK£318.2m | -UK£167,469,254.00 | n/a | -8.1x | 4.3x |
| Thu, 09 Apr 2026 | UK£1.3b | UK£323.0m | -UK£156,192,254.00 | 9.1x | -8.5x | 4.1x |
| Sat, 07 Mar 2026 | UK£1.4b | UK£324.0m | -UK£161,423,254.00 | 10.7x | -8.7x | 4.3x |
| Mon, 02 Feb 2026 | UK£1.7b | UK£304.6m | -UK£159,441,254.00 | 7.7x | -10.9x | 5.7x |
| Wed, 31 Dec 2025 | UK£1.4b | UK£304.6m | -UK£159,441,254.00 | 8.1x | -9x | 4.7x |
| Fri, 28 Nov 2025 | UK£1.6b | UK£303.9m | -UK£162,910,254.00 | 7.3x | -9.6x | 5.1x |
| Sun, 26 Oct 2025 | UK£1.6b | UK£304.3m | -UK£163,156,254.00 | 8.9x | -9.8x | 5.3x |
| Tue, 23 Sep 2025 | UK£1.8b | UK£313.5m | -UK£158,190,352.00 | 5.7x | -11.3x | 5.7x |
| Thu, 21 Aug 2025 | UK£2.3b | UK£291.9m | -UK£160,968,352.00 | 6.5x | -14x | 7.7x |
| Sat, 19 Jul 2025 | UK£1.6b | UK£291.9m | -UK£160,968,352.00 | 6.5x | -10.1x | 5.6x |
| Mon, 16 Jun 2025 | UK£1.6b | UK£319.4m | -UK£190,737,820.90 | 7x | -8.1x | 4.9x |
| Wed, 14 May 2025 | UK£1.7b | UK£313.2m | -UK£192,945,372.80 | 11.7x | -8.9x | 5.5x |
| Fri, 11 Apr 2025 | UK£1.5b | UK£315.6m | -UK£186,402,220.30 | 5.9x | -8.1x | 4.8x |
| Sun, 09 Mar 2025 | UK£1.5b | UK£321.0m | -UK£182,103,508.40 | 6.7x | -8.4x | 4.8x |
| Tue, 04 Feb 2025 | UK£2.1b | UK£307.1m | -UK£195,696,526.32 | 7.4x | -10.6x | 6.7x |
| Thu, 02 Jan 2025 | UK£1.9b | UK£306.7m | -UK£195,379,548.00 | 8x | -9.5x | 6x |
| Sat, 30 Nov 2024 | UK£2.1b | UK£306.2m | -UK£192,778,382.96 | 8.5x | -10.8x | 6.8x |
| Mon, 28 Oct 2024 | UK£2.0b | UK£304.7m | -UK£192,569,494.30 | 10.8x | -10.4x | 6.6x |
| Wed, 25 Sep 2024 | UK£2.1b | UK£303.6m | -UK£191,484,550.50 | 11.5x | -11.1x | 7x |
| Fri, 23 Aug 2024 | UK£1.8b | UK£295.9m | -UK£188,475,280.20 | 12.3x | -9.7x | 6.2x |
| Sun, 21 Jul 2024 | UK£1.7b | UK£295.3m | -UK£189,720,861.18 | 12.9x | -8.9x | 5.7x |
| Tue, 18 Jun 2024 | UK£1.6b | UK£295.7m | -UK£189,901,433.73 | 11.5x | -8.2x | 5.3x |
| Thu, 16 May 2024 | UK£1.7b | UK£294.6m | -UK£187,508,970.83 | 7325x | -8.9x | 5.7x |
| Sat, 13 Apr 2024 | UK£1.6b | UK£317.8m | -UK£178,579,491.35 | 12.2x | -9x | 5.1x |
| Mon, 11 Mar 2024 | UK£1.9b | UK£292.8m | -UK£212,325,303.08 | 7210.6x | -9x | 6.5x |
| Wed, 07 Feb 2024 | UK£2.1b | UK£286.0m | -UK£189,374,598.47 | 6968.2x | -11.3x | 7.5x |
| Fri, 05 Jan 2024 | UK£3.1b | UK£450.0m | -UK£174,058,355.00 | 58.9x | -18x | 7x |
| Sun, 03 Dec 2023 | UK£3.1b | UK£455.2m | -UK£168,866,409.00 | 50.7x | -18.2x | 6.7x |
| Tue, 31 Oct 2023 | UK£3.0b | UK£458.7m | -UK£165,613,674.00 | 46.7x | -18x | 6.5x |
| Thu, 28 Sep 2023 | UK£3.0b | UK£450.6m | -UK£168,382,875.00 | 67.5x | -17.7x | 6.6x |
| Sat, 26 Aug 2023 | UK£3.1b | UK£476.5m | -UK£126,824,223.00 | 70.6x | -24.3x | 6.5x |
| Mon, 24 Jul 2023 | UK£3.5b | UK£476.2m | -UK£124,493,188.00 | 69.6x | -27.8x | 7.3x |
Price to Earnings Ratio
-27.8x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.8x is higher than the industry's current PS ratio of 4.0x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | 1.12% | |
| Healthcare | -2.95% | |
| Life Sciences | -2.91% | |
| Clinical Research and Equipment | -2.91% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PRM Proteome Sciences | UK£0.019 | 14.7% +UK£876.8k | -35.9% | PS1.8x | |
| OBD Oxford BioDynamics | UK£0.0013 | 18.2% +UK£858.2k | -71.2% | PS4.7x | |
| PYC Physiomics | UK£0.0055 | 29.4% +UK£566.5k | 15.8% | PS2.5x |
